Transcat, Inc. provides laboratory instrument and calibration services in the United States, Canada, and internationally. The company is headquartered in Rochester, New York.
| Revenue (TTM) | $319.69M |
| Gross Profit (TTM) | $103.75M |
| EBITDA | $41.33M |
| Operating Margin | 1.02% |
| Return on Equity | 2.73% |
| Return on Assets | 2.40% |
| Revenue/Share (TTM) | $34.31 |
| Book Value | $31.80 |
| Price-to-Book | 2.37 |
| Price-to-Sales (TTM) | 2.31 |
| EV/Revenue | 2.612 |
| EV/EBITDA | 20.90 |
| Quarterly Earnings Growth (YoY) | -61.10% |
| Quarterly Revenue Growth (YoY) | 25.60% |
| Shares Outstanding | $9.33M |
| Float | $9.12M |
| % Insiders | 2.26% |
| % Institutions | 101.57% |
Volatility is currently contracting